Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies

August 1, 2001
Shabbir T. Anik, PhD

Shabbir T. Anik, PhD, is vice­president of scientific affairs and global PDS operations, Patheon, Inc., 2100 Syntex Court, Mississauga, ON, Canada L5N 7K9, tel. 650.962.8406.

,
Colin M. Minchom, PhD

Colin M. Minchom, PhD, is group director of PDS operations, Toronto region operations at Patheon, Inc.

Pharmaceutical Technology, Pharmaceutical Technology-08-01-2001, Volume 2001 Supplement, Issue 2

Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.